10x Genomics Inc share price logo

10x Genomics Inc Share Price

NASDAQ: TXG

Mid Cap

$22.55

-0.47

(-2.04%)

Live

as on

10x Genomics Inc Stock Performance

as on April 10, 2026 at 1:11 am IST

  • Day's Low

    Day's High

    $22.21
    $23.02
    downward going graph

    1.51%

    Downside

    2.08%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $6.94
    $23.65
    downward going graph

    69.22%

    Downside

    4.88%

    Upside

    downward going graph

10x Genomics Inc share price movements today

Previous Close
$23.02
Open
$22.95
Volume
245.6K
Day's Low - High
$22.21 - $23.02
52 Week Low - High
$6.94 - $23.65

10x Genomics Inc Historical Returns

1 Month Return
+ 10.09 %
3 Month Return
+ 12.51 %
1 Year Return
+ 165.51 %
3 Year Return
-55.78 %
5 Year Return
-88.17 %

10x Genomics Inc Stock Fundamentals & Key Indicators

Check 10x Genomics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.8B

EPS (TTM)

-0.1333

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-10.12

Industry PE ratio

15.729518072289157

PEG Ratio

0

EBITDA

-64.1M

Revenue (TTM)

642.8M

Profit Margin

-6.77%

Return On Equity TTM

-5.78%

10x Genomics Inc Stock Valuation

Track how 10x Genomics Inc P/E has moved over time to understand its valuation trends.

10x Genomics Inc in the last 5 years

  • Overview

  • Trends

Lowest (-110.74x)

March 31, 2022

Today (-10.12x)

April 9, 2026

Industry (15.73x)

April 9, 2026

Highest (61.00x)

March 31, 2026

LowHigh

Today’s Price to Earnings Ratio: -10.12x

10x Genomics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of 10x Genomics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
10x Genomics Inc image
10x Genomics Inc
BUY$2.8B-88.17%-10.12-6.77%
Healthequity Inc image
Healthequity Inc
BUY$6.9B18.2%32.9616.39%
Veeva Systems Inc. image
Veeva Systems Inc.
BUY$28.4B-36.96%31.7728.45%
Brightspring Health Services Inc. image
Brightspring Health Services Inc.
BUY$8.4BNA91.41.48%
Tempus Ai image
Tempus Ai
NA$8.4BNA-25.89-19.27%

Stock Returns calculator for 10x Genomics Inc Stock including INR - Dollar returns

The 10x Genomics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

10x Genomics Inc investment value today

Current value as on today

₹2,78,031

Returns

₹1,78,031

(+178.03%)

Returns from 10x Genomics Inc Stock

₹1,60,092 (+160.09%)

Dollar Impact

₹17,939 (+17.94%)

Analyst Recommendation on 10x Genomics Inc Stock

Based on 20 analysts

BUY

75.00%

Buy

20.00%

Hold

5.00%

Sell

Based on 20 analysts, 75% of analysts recommend a 'BUY' rating for 10x Genomics Inc. Average target price of $20.15

10x Genomics Inc Share Price Target

Get share price movements and forecasts by analysts on 10x Genomics Inc.

What analysts predicted

-11.91%DOWNSIDE

Target Price

$20.15

Current Price

$22.55

Analyzed by

20 Analysts

Target

$20.15

10x Genomics Inc target price $20.15, a slight downside of -11.91% compared to current price of $22.55. According to 20 analysts rating.

10x Genomics Inc Stock’s Investor Sentiment and Interest

Search interest for 10x Genomics Inc Stock has increased by 26% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:26% versus previous 30 day period

10x Genomics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
153
183
141
153
151
165
154
172
149
166
Gross Profit
95
115
92
104
106
110
105
125
100
113
Operating Income
-94
-55
-61
-41
-41
-49
-39
30
-32
-19
EBITDA
-80
-34
-46
-26
-23
-37
-23
46
-15
-19
Interest Expense
0
0
0
0
0
0
-
0
0
-
Depreciation
11
11
11
10
10
10
9
9
12
12
Income Before Tax
-91
-46
-57
-37
-34
-48
-33
36
-28
-15
Income Tax Expense
1
2
2
0
1
0
0
2
0
1
Net Income
-92
-48
-59
-37
-35
-49
-34
34
-27
-16
Net Profit Margin
-60.52%
-26.61%
-42.52%
-24.75%
-23.58%
-29.71%
-22.18%
19.97%
-18.44%
-9.79%

10x Genomics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
71
146
245
298
490
516
618
610
642
Gross Profit
60
117
184
240
416
396
409
414
443
Operating Income
-18
-110
-29
-85
-52
-167
-265
-194
-110
EBITDA
-13
-106
-20
-513
-24
-128
-205
-133
-110
Interest Expense
0
2
3
1
0
0
0
0
-
Depreciation
4
3
7
19
28
33
43
43
43
Income Before Tax
-18
-112
-31
-534
-53
-161
-248
-177
-39
Income Tax Expense
0
0
0
8
4
4
6
4
3
Net Income
-18
-112
-31
-542
-58
-166
-255
-182
-43
Net Profit Margin
-26.39%
-76.88%
-12.71%
-181.61%
-11.87%
-32.15%
-41.23%
-29.90%
-6.77%

10x Genomics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-48
-59
-37
-35
-49
-34
34
-27
-16
Operating Cash Flow
25
-15
7
21
-6
34
17
43
40
Investing Cash Flow
13
10
11
-3
-51
-1
0
-8
-1
Financing Cash Flow
5
1
4
0
4
0
3
0
2
Change in Cash
44
-3
24
18
-54
32
20
34
41

10x Genomics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-112
-31
-542
-58
-166
-255
-182
-43
Operating Cash Flow
-76
34
-217
-21
-33
-15
6
136
Investing Cash Flow
-6
-42
-38
-106
-350
133
-32
-13
Financing Cash Flow
105
414
468
35
15
13
10
6
Change in Cash
22
406
212
-92
-368
131
-15
129

Global Institutional Holdings in 10x Genomics Inc

Funds
Holdings
ARK Investment Management LLC
9.3%
ARK Investment Management LLC
9.92%
Amova Asset Management Americas, Inc
4.29%
Quantinno Capital Management LP
3.65%
The Goldman Sachs Group Inc
2.42%
See all

10x Genomics Inc News & Key Events

    Insights on 10x Genomics Inc

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, TXG has outperformed top 5 stocks with highest market-cap in its industry

    • imgPOSITIVE IMPACT

      Best in 1 Year

      img

      In the last 1 year, TXG has outperformed top 5 stocks with highest market-cap in its industry

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 6 months, TXG stock has moved up by 96.6%

    • imgPOSITIVE IMPACT

      Profit Spike

      img

      Netprofit is up for the last 2 quarters, -27.47M → -16.25M (in $), with an average increase of 69.0% per quarter

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 2 quarters, 149.00M → 166.03M (in $), with an average increase of 10.3% per quarter

    About 10x Genomics Inc

    advancing human health requires a greater understanding of biology, and that understanding starts with the cell. we enable researchers to drive exponential progress in oncology, immunology, neuroscience, and more with novel single cell, spatial, and in situ tools that have been cited in over 3,000 publications and continually improved by our dedicated scientific team. our aim: to develop innovative instruments, reagents, and software that allow you to see your biological system at a resolution that matches its complexity.
    Organisation10x Genomics Inc
    Headquarters6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588-3260
    IndustryCommercial Services
    CEODr. Serge Saxonov Ph.D.
    E-voting on sharesClick here to vote

    Key Management of 10x Genomics Inc

    Name

    Title

    Mr. Adam S. Taich

    CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer

    Mr. Jim Goodrich

    Chief of Global Operations

    Mr. Michael Schnall-Levin Ph.D.

    Founding Scientist & CTO

    Mr. Jens Durruthy

    Associate Director of Product Management

    Ms. Mennah Moustafa

    Chief Commercial Officer

    Dr. Serge Saxonov Ph.D.

    Co-Founder, CEO & Director

    Dr. Benjamin J. Hindson Ph.D.

    Co-Founder, President, Chief Scientific Officer & Director

    Ms. Cassie Corneau

    Manager of Investor Relations & Strategic Finance

    Dr. Randy Wu

    General Counsel and Secretary

    FAQs

    What is 10x Genomics Inc share price today?

    10x Genomics Inc share price today is $22.55 as on . 10x Genomics Inc share today touched a day high of $23.02 and a low of $22.21.

    What is the 52 week high and 52 week low for 10x Genomics Inc share?

    10x Genomics Inc share touched a 52 week high of $23.65 on and a 52 week low of $6.94 on . 10x Genomics Inc stock price today i.e. is trending at $22.55,which is 4.65% down from its 52 week high and 224.93% up from its 52 week low.

    What is 10x Genomics Inc's market capitalisation today?

    10x Genomics Inc market capitalisation is $0.00T as on .

    How to invest in 10x Genomics Inc Stock (TXG) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for 10x Genomics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in 10x Genomics Inc Shares that will get you 0.0665 shares as per 10x Genomics Inc share price of $22.55 per share as on April 9, 2026 at 7:41 pm IST.

    What is the minimum amount required to buy 10x Genomics Inc Stock (TXG) from India?

    Indian investors can start investing in 10x Genomics Inc (TXG) shares with as little as ₹92.637 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹926.37 in 10x Genomics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on 10x Genomics Inc share’s latest price of $22.55 as on April 9, 2026 at 7:41 pm IST, you will get 0.4435 shares of 10x Genomics Inc. Learn more about fractional shares .

    What are the returns that 10x Genomics Inc has given to Indian investors in the last 5 years?

    10x Genomics Inc stock has given -88.17% share price returns and 24.53% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?